Viral-induced CD28 loss evokes costimulation independent alloimmunity

Journal of Surgical Research

Volumn 196, Issue 2, 2015, Pages 241-246

  Mou, Danny ^a   Espinosa, Jaclyn E ^a   Stempora, Linda ^a   Iwakoshi, Neal N ^a   Kirk, Allan D ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunity; Belatacept; BK; CD28; CMV; HV68

Indexed keywords

ALLOANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; EPSTEIN BARR VIRUS INFECTION; HERPES VIRUS INFECTION; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMORY T LYMPHOCYTE; MIXED LYMPHOCYTE REACTION; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; VIRUS INFECTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CD8+ T LYMPHOCYTE; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; MUROMEGALOVIRUS; POLYOMAVIRUS;

ANIMALS; ANTIGENS, CD28; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; INTERFERON-GAMMA; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; POLYOMAVIRUS; TRANSPLANTATION IMMUNOLOGY; VIRUS DISEASES;

EID: 84930378840     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.02.033     Document Type: Article

References (24)

1. D. Mou, J. Espinosa, D.J. Lo, and A.D. Kirk CD28 negative T cells: is their loss our gain? Am J Transplant 14 2014 2460
2. K.E. Weck, M.L. Barkon, L.I. Yoo, S.H. Speck, and H.I. Virgin Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68 J Virol 70 1996 6775
3. D. Stapler, E.D. Lee, and S.A. Selvaraj Expansion of effector memory TCR Vbeta4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance J Immunol 180 2008 3190
4. P. Neri, L. Ren, and K. Gratton Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors Blood 118 2011 6368
5. F. Vincenti, B. Charpentier, and Y. Vanrenterghem A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant 10 2010 535
6. A.B. Adams, M.A. Williams, and T.R. Jones Heterologous immunity provides a potent barrier to transplantation tolerance J Clin Invest 111 2003 1887
7. L.K. Selin, and M.A. Brehm Frontiers in nephrology: heterologous immunity, T cell cross-reactivity, and alloreactivity J Am Soc Nephrol 18 2007 2268
8. R.M. Welsh, and L.K. Selin No one is naive: the significance of heterologous T-cell immunity Nat Rev Immunol 2 2002 417
9. L.K. Selin, M.A. Brehm, and Y.N. Naumov Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity Immunol Rev 211 2006 164
10. A. Valujskikh, and X.C. Li Frontiers in nephrology: T cell memory as a barrier to transplant tolerance J Am Soc Nephrol 18 2007 2252
11. J.O. Pestana, J.M. Grinyo, and Y. Vanrenterghem Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys Am J Transplant 12 2012 630
12. W.H. Kitchens, D. Haridas, M.E. Wagener, M. Song, and M.L. Ford Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses Transplantation 93 2012 997
13. R.M. Welsh, T.G. Markees, and B.A. Woda Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody J Virol 74 2000 2210
14. W.H. Kitchens, D. Haridas, and M.E. Wagener Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells Am J Transplant 12 2012 69
15. S. Ehtisham, N.P. Sunil-Chandra, and A.A. Nash Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells J Virol 67 1993 5247
16. U. Karrer, M. Wagner, and S. Sierro Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses J Virol 78 2004 2255
17. R.D. Cardin, J.W. Brooks, S.R. Sarawar, and P.C. Doherty Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells J Exp Med 184 1996 863
18. D.M. Haig Subversion and piracy: DNA viruses and immune evasion Res Vet Sci 70 2001 205
19. J.J. Wilson, E. Lin, and C.D. Pack Gamma interferon controls mouse polyomavirus infection in vivo J Virol 85 2011 10126
20. E. Flano, S.M. Husain, J.T. Sample, D.L. Woodland, and M.A. Blackman Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages J Immunol 165 2000 1074
21. R.A. Tripp, A.M. Hamilton-Easton, and R.D. Cardin Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med 185 1997 1641
22. E.T. Clambey, H.W. Virgin, and S.H. Speck Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency J Virol 74 2000 1973
23. A.G. Evans, J.M. Moser, L.T. Krug, V. Pozharskaya, A.L. Mora, and S.H. Speck A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology J Exp Med 205 2008 669
24. N.P. Weng, A.N. Akbar, and J. Goronzy CD28(-) T cells: their role in the age-associated decline of immune function Trends Immunol 30 2009 306